Prospective Evaluation Analysis and Kinetics Registry

CompletedOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

February 4, 2022

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Atrial Arrhythmia
Interventions
DRUG

Sotalol Injection

Standard of care IV sotalol infusion for atrial arrhythmias

Trial Locations (1)

84112

University of Utah, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

AltaThera Pharmaceuticals, LLC

UNKNOWN

lead

University of Utah

OTHER

NCT05247320 - Prospective Evaluation Analysis and Kinetics Registry | Biotech Hunter | Biotech Hunter